Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Other Accumulated Expenses (2020 - 2022)

Rapid Micro Biosystems' Other Accumulated Expenses history spans 3 years, with the latest figure at $200000.0 for Q2 2022.

  • For Q2 2022, Other Accumulated Expenses fell 63.1% year-over-year to $200000.0; the TTM value through Jun 2022 reached $200000.0, down 63.1%, while the annual FY2021 figure was $338000.0, 199.12% up from the prior year.
  • Other Accumulated Expenses for Q2 2022 was $200000.0 at Rapid Micro Biosystems, up from $86000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $694000.0 in Q3 2021 and bottomed at $86000.0 in Q1 2022.
  • The 3-year median for Other Accumulated Expenses is $269000.0 (2021), against an average of $328833.3.
  • The largest annual shift saw Other Accumulated Expenses soared 199.12% in 2021 before it crashed 63.1% in 2022.
  • A 3-year view of Other Accumulated Expenses shows it stood at $113000.0 in 2020, then soared by 199.12% to $338000.0 in 2021, then crashed by 40.83% to $200000.0 in 2022.
  • Per Business Quant, the three most recent readings for RPID's Other Accumulated Expenses are $200000.0 (Q2 2022), $86000.0 (Q1 2022), and $338000.0 (Q4 2021).